• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用纵向靶向最大似然估计评估胰岛素抵抗轨迹对心血管疾病风险的影响。

Assessing the impact of insulin resistance trajectories on cardiovascular disease risk using longitudinal targeted maximum likelihood estimation.

作者信息

Feng Yaning, Yin Liangying, Huang Haoran, Hu Yongheng, Lin Sitong

机构信息

School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, China.

School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

Cardiovasc Diabetol. 2025 Mar 10;24(1):112. doi: 10.1186/s12933-025-02651-6.

DOI:10.1186/s12933-025-02651-6
PMID:40065358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11895167/
Abstract

BACKGROUND

Cardiovascular disease (CVD) is closely associated with Insulin Resistance (IR). However, there is limited research on the relationship between trajectories of IR and CVD incidence, considering both time-invariant and time-varying confounders. We employed advanced causal inference methods to evaluate the longitudinal impact of IR trajectories on CVD risk.

METHODS

The data for this study were extracted from a Chinese nationwide cohort, named China Health and Retirement Longitudinal Study (CHARLS). Triglyceride-glucose (TyG) index and TyG body mass index (BMI) were used as surrogate markers for IR, and their changes were recorded as exposures. Longitudinal targeted maximum likelihood estimation (LTMLE) was used to study how dynamic shifts in IR trajectories (i.e., increase, decrease, etc.) influence long-term CVD risk, adjusting for both time-invariant and time-varying confounders.

RESULTS

A total of 3,966 participants were included in the analysis, with 2,152 (54.3%) being female. The average age at baseline was 58.28 years. Over the course of a 7-year follow-up period, 499 (12.6%) participants developed CVD. Four distinct trajectories of TyG index and TyG-BMI were identified: low stable, increasing, decreasing, and high stable. LTMLE analyses revealed individuals in the 'high stable' and 'increasing' groups had a significantly higher risk of developing CVD compared to those in the 'low stable' group, while the 'decreasing' group showed no significant differences. Specifically, when the exposure was set as TyG-BMI, the odds of CVD in the 'high stable' group were 1.694 (95% CI: 1.361-2.108) times higher than in the 'low stable' group. Similar trends were observed across other models, with ORs of 1.708 (95% CI: 1.367-2.134) in Model 2, 1.389 (1.083-1.782) in Model 3, 1.675 (1.185-2.366) in Model 4, and 1.375 (95% CI:1.07 - 1.768) in Model 5. When the exposure was changed to the TyG index, the results remained consistent, with a slightly lower magnitude of the odds ratios.

CONCLUSIONS

High stable and increasing TyG-BMI and TyG index trajectories were associated with the risk of CVD. TyG-BMI consistently exhibited higher odds ratios (ORs) of CVD risk when comparing with TyG index. Early identification of IR trajectories could provide insights for preventing CVD later in life.

摘要

背景

心血管疾病(CVD)与胰岛素抵抗(IR)密切相关。然而,考虑到时间不变和随时间变化的混杂因素,关于IR轨迹与CVD发病率之间关系的研究有限。我们采用先进的因果推断方法来评估IR轨迹对CVD风险的纵向影响。

方法

本研究的数据取自一项名为中国健康与养老追踪调查(CHARLS)的全国性队列研究。甘油三酯-葡萄糖(TyG)指数和TyG体重指数(BMI)被用作IR的替代标志物,并记录其变化作为暴露因素。纵向靶向最大似然估计(LTMLE)用于研究IR轨迹的动态变化(即增加、减少等)如何影响长期CVD风险,同时调整时间不变和随时间变化的混杂因素。

结果

共有3966名参与者纳入分析,其中女性2152名(54.3%)。基线时的平均年龄为58.28岁。在7年的随访期内,499名(12.6%)参与者发生了CVD。确定了TyG指数和TyG-BMI的四种不同轨迹:低稳定、上升、下降和高稳定。LTMLE分析显示,与“低稳定”组相比,“高稳定”组和“上升”组的个体发生CVD的风险显著更高,而“下降”组无显著差异。具体而言,当暴露设定为TyG-BMI时,“高稳定”组发生CVD的几率比“低稳定”组高1.694倍(95%CI:1.361-2.108)。在其他模型中也观察到类似趋势,模型2中的比值比为1.708(95%CI:1.367-2.134),模型3中为1.389(1.083-1.782),模型4中为1.675(1.185-2.366),模型5中为1.375(95%CI:1.07-1.768)。当暴露改为TyG指数时,结果保持一致,比值比幅度略低。

结论

TyG-BMI和TyG指数的高稳定及上升轨迹与CVD风险相关。与TyG指数相比,TyG-BMI在CVD风险方面始终表现出更高的比值比。早期识别IR轨迹可为预防晚年CVD提供见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc8/11895167/8e548bf7dc8d/12933_2025_2651_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc8/11895167/c84aa2e8d68a/12933_2025_2651_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc8/11895167/a63289c21ad6/12933_2025_2651_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc8/11895167/8e548bf7dc8d/12933_2025_2651_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc8/11895167/c84aa2e8d68a/12933_2025_2651_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc8/11895167/a63289c21ad6/12933_2025_2651_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc8/11895167/8e548bf7dc8d/12933_2025_2651_Fig3_HTML.jpg

相似文献

1
Assessing the impact of insulin resistance trajectories on cardiovascular disease risk using longitudinal targeted maximum likelihood estimation.使用纵向靶向最大似然估计评估胰岛素抵抗轨迹对心血管疾病风险的影响。
Cardiovasc Diabetol. 2025 Mar 10;24(1):112. doi: 10.1186/s12933-025-02651-6.
2
Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0-3: a nationwide prospective cohort study.在心血管-肾脏-代谢综合征 0-3 期人群中,甘油三酯-葡萄糖-体重指数与未来心血管疾病风险的关系:一项全国性前瞻性队列研究。
Cardiovasc Diabetol. 2024 Aug 7;23(1):292. doi: 10.1186/s12933-024-02352-6.
3
The interaction between triglyceride-glucose index and visceral adiposity in cardiovascular disease risk: findings from a nationwide Chinese cohort.甘油三酯-葡萄糖指数与内脏肥胖在心血管疾病风险中的相互作用:来自全国性中国队列的研究结果。
Cardiovasc Diabetol. 2024 Nov 27;23(1):427. doi: 10.1186/s12933-024-02518-2.
4
Impact of the baseline insulin resistance surrogates and their longitudinal trajectories on cardiovascular disease (coronary heart disease and stroke): a prospective cohort study in rural China.基线胰岛素抵抗替代物及其纵向轨迹对心血管疾病(冠心病和中风)的影响:中国农村的一项前瞻性队列研究。
Front Endocrinol (Lausanne). 2023 Dec 22;14:1259062. doi: 10.3389/fendo.2023.1259062. eCollection 2023.
5
Triglyceride-glucose-body mass index and the incidence of cardiovascular diseases: a meta-analysis of cohort studies.甘油三酯-葡萄糖-体重指数与心血管疾病发病率:队列研究的荟萃分析
Cardiovasc Diabetol. 2025 Jan 22;24(1):34. doi: 10.1186/s12933-025-02584-0.
6
Triglyceride-glucose index as a mediator of body mass index and cardiovascular disease in middle-aged and older Chinese adults: a nationally representative longitudinal cohort study.甘油三酯-葡萄糖指数作为中国中老年成年人身体质量指数与心血管疾病之间的中介因素:一项全国代表性纵向队列研究
Front Endocrinol (Lausanne). 2024 Dec 23;15:1431087. doi: 10.3389/fendo.2024.1431087. eCollection 2024.
7
Association between triglyceride glucose-waist height ratio index and cardiovascular disease in middle-aged and older Chinese individuals: a nationwide cohort study.甘油三酯-葡萄糖-腰围比值指数与中国中老年人群心血管疾病的关系:一项全国性队列研究。
Cardiovasc Diabetol. 2024 Jul 11;23(1):247. doi: 10.1186/s12933-024-02336-6.
8
Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China.中国中老年人群中甘油三酯-葡萄糖-体重指数累积平均值与心血管疾病发病的相关性:一项前瞻性全国队列研究。
Cardiovasc Diabetol. 2024 Jan 6;23(1):16. doi: 10.1186/s12933-023-02114-w.
9
Relationship between triglyceride glucose-body mass index baselines and variation with future cardiovascular diseases risk in the middle-aged and elderly individuals.中年及老年个体中甘油三酯葡萄糖-体质指数基线与未来心血管疾病风险变化之间的关系。
Front Endocrinol (Lausanne). 2025 Jan 27;16:1514660. doi: 10.3389/fendo.2025.1514660. eCollection 2025.
10
Assessment of six insulin resistance surrogate indexes for predicting stroke incidence in Chinese middle-aged and elderly populations with abnormal glucose metabolism: a nationwide prospective cohort study.评估六种胰岛素抵抗替代指标对中国糖代谢异常中老年人群卒中发病率的预测价值:一项全国性前瞻性队列研究
Cardiovasc Diabetol. 2025 Feb 6;24(1):56. doi: 10.1186/s12933-025-02618-7.

本文引用的文献

1
Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: a competing risk analysis.甘油三酯-葡萄糖指数变化轨迹及其与全因和心血管死亡率的关系:竞争风险分析。
Cardiovasc Diabetol. 2024 Oct 15;23(1):364. doi: 10.1186/s12933-024-02457-y.
2
Association between METS-IR and heart failure: a cross-sectional study.代谢综合征胰岛素抵抗(METS-IR)与心力衰竭之间的关联:一项横断面研究。
Front Endocrinol (Lausanne). 2024 Jul 1;15:1416462. doi: 10.3389/fendo.2024.1416462. eCollection 2024.
3
Association between triglyceride glucose-body mass index and long-term adverse outcomes of heart failure patients with coronary heart disease.
三酰甘油葡萄糖体重指数与冠心病心力衰竭患者长期不良结局的关系。
Cardiovasc Diabetol. 2024 May 9;23(1):162. doi: 10.1186/s12933-024-02213-2.
4
Association of single-point insulin sensitivity estimator index (SPISE) with future cardiovascular outcomes in patients with type 2 diabetes.单点胰岛素敏感性估算指数(SPISE)与 2 型糖尿病患者未来心血管结局的关系。
Diabetes Obes Metab. 2024 Jul;26(7):2820-2829. doi: 10.1111/dom.15600. Epub 2024 Apr 15.
5
The association between triglyceride glucose-body mass index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study from MIMIC-IV database.在 MIMIC-IV 数据库中,三酰甘油-葡萄糖-体重指数与房颤危重症患者全因死亡率的关系:一项回顾性研究。
Cardiovasc Diabetol. 2024 Feb 10;23(1):64. doi: 10.1186/s12933-024-02153-x.
6
Association of insulin resistance indicators with hepatic steatosis and fibrosis in patients with metabolic syndrome.代谢综合征患者胰岛素抵抗指标与肝脂肪变性和纤维化的关系。
BMC Gastroenterol. 2024 Jan 9;24(1):26. doi: 10.1186/s12876-023-03095-6.
7
The triglyceride glucose index trajectory is associated with hypertension: a retrospective longitudinal cohort study.甘油三酯-葡萄糖指数轨迹与高血压相关:一项回顾性纵向队列研究。
Cardiovasc Diabetol. 2023 Dec 15;22(1):347. doi: 10.1186/s12933-023-02087-w.
8
Global Burden of Cardiovascular Diseases and Risks, 1990-2022.1990 - 2022年心血管疾病及其风险的全球负担
J Am Coll Cardiol. 2023 Dec 19;82(25):2350-2473. doi: 10.1016/j.jacc.2023.11.007.
9
Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study.甘油三酯-葡萄糖指数、肾功能与心血管疾病:一项全国性队列研究。
Cardiovasc Diabetol. 2023 Nov 28;22(1):325. doi: 10.1186/s12933-023-02055-4.
10
Insulin and aging - a disappointing relationship.胰岛素与衰老——一段令人失望的关系。
Front Endocrinol (Lausanne). 2023 Oct 3;14:1261298. doi: 10.3389/fendo.2023.1261298. eCollection 2023.